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Abstract: A liposomes-in-hydrogel system as an advanced wound dressing for dermal delivery
of curcumin was proposed for improved chronic wound therapy. Curcumin, a multitargeting
poorly soluble active substance with known beneficial properties for improved wound healing, was
incorporated in deformable liposomes to overcome its poor solubility. Chitosan hydrogel served as a
vehicle providing superior wound healing properties. The novel system should assure sustained skin
delivery of curcumin, and increase its retention at the skin site, utilizing both curcumin and chitosan to
improve the therapy outcome. To optimize the properties of the formulation and determine the effect
of the liposomal charge on the hydrogel properties, curcumin-containing deformable liposomes (DLs)
with neutral (NDLs), cationic (CDLs), and anionic (ADLs) surface properties were incorporated in
chitosan hydrogel. The charged DLs affected the hydrogel’s hardness, cohesiveness, and adhesiveness.
Importantly, the incorporation of DLs, regardless of their surface charge, in chitosan hydrogel did not
decrease the system’s bioadhesion to human skin. Stability testing revealed that the incorporation of
CDLs in hydrogel preserved hydrogel´s bioadhesiveness to a higher degree than both NDLs and
ADLs. In addition, CDLs-in-hydrogel enabled the most sustained skin penetration of curcumin.
The proposed formulation should be further evaluated in a chronic wound model.
Keywords: curcumin; deformable liposomes; liposome surface charge; hydrogel; chitosan;
wound therapy
1. Introduction
The treatment of chronic wounds is one of the most important global health care issues in the
aging society. Chronic wounds are challenging to treat due to the diversity of factors contributing to
slow/impaired healing. The hostile environment of the wound comprising degradative enzymes and
elevated pH, as well as the complexity of physiological processes, requires an effective advanced drug
delivery system as a wound dressing [1,2]. An ideal wound dressing should reduce infection, moisturize
the wound, stimulate the healing mechanism, accelerate the wound closure, and reduce/control scar
formation [3].
Recently, the incessant release of free radicals has been proposed as one of the key factors
responsible for activation of the inflammatory system, leading to impaired repair of the wound [4].
Therefore, the effective control of free radical levels in the wound and subsequent inflammation could
assist in enhanced wound healing and scar control. Various antioxidants could be utilized to control
free radicals during wound healing.
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Curcumin has been proposed as one of the most promising [5]. Moreover, curcumin is a molecule
able to active multiple pathways, contributing to improved wound healing [6]. The antioxidant,
anti-inflammatory, and anti-bacterial properties of this pleiotropic molecule need to be more
utilized [7,8]. Although curcumin is a very promising molecule to be included in wound dressings,
its hydrophobicity, extensive metabolism, and limited skin penetration often hamper its wider
use [9]. We have recently proven that curcumin, a multitargeting active substance, exhibits superior
anti-inflammatory properties when incorporated in tailored deformable liposomes [10]. In this work,
we went a step further in the development of curcumin-based wound dressings and combined the
beneficial properties of curcumin as an active moiety and chitosan hydrogel as a superior vehicle to
form a bioactive wound dressing targeting the treatment of chronic wounds.
An ideal dressing should assure an enhanced therapeutic outcome and reduction of pain accompanied
with wound dressing changes [11]. Among the possible material to be used in the manufacturing of
bioactive dressings, natural polymer-based wound dressings, such as hydrogels, represent promising
advanced delivery systems with a low risk of toxicity and side effects due to their biodegradability and
biocompatibility [12,13]. Hydrogels mimic the biochemical, biomechanical, and structural features of
the extracellular matrix (ECM), serving as superior matrices for wound treatment [13,14]. Hydrogels
additionally possess good bioadhesiveness that can contribute to a prolonged retention time of the
incorporated drug/active substance at the wounded skin site. This, together with the sustained drug
release via hydrogel, can result in higher drug/active substances’ concentrations at the skin site while
reducing possible systemic absorption and consequent adverse effects [15].
Chitosan represents one of the most studied natural polymers for the development of effective
hydrogel-based wound dressings due to its numerous intrinsic biological properties. Its biocompatibility
and bioadhesiveness, together with intrinsic bacteriostatic effect, make this biopolymer effective in
promoting wound healing while also preventing biofilm formation [16,17]. In spite of the numerous
advantages of chitosan hydrogels, the hydrophilic environment provided by chitosan hydrogel limits
the incorporation of lipophilic drugs/active compounds and remains a pharmaceutical challenge.
Liposomes as carriers for poorly soluble drugs/active molecules assist in overcoming this hydrogel
limitation; the combination of these two delivery systems is a promising approach to achieve controlled
dermal drug delivery and effective localized skin therapy [18–20]. The liposomal phospholipid bilayers
allow the incorporation of lipophilic substances, improving their solubilization and enabling their
inclusion into the hydrophilic chitosan hydrogel. Moreover, the ability of liposomes to assure sustained
drug/substance release might improve targeted drug delivery to the specific skin layer(s) [19,21].
Liposomes also benefit from their incorporation in the hydrogel vehicle. The hydrogel can prevent
rapid liposome clearance from the skin site and additionally protect from rapid degradation by
preserving their membrane integrity [22]. Moreover, incorporation of liposomes in hydrogel will confer
adequate viscosity to the liposomal dispersions to be topically administered [23].
The drug/substance release from a liposomes-in-hydrogel system is determined by the hydrogel
properties, such as the polymer composition, mesh size, and porosity, combined with the liposomal
physicochemical characteristics, namely the liposomal composition, size, and surface charge.
In addition, the lipophilicity of the incorporated drug needs to be considered [24]. To the best
of our knowledge, relatively little has been published on the incorporation of deformable liposomes
(DLs) in chitosan hydrogel. DLs have shown superior ability in promoting drug penetration into the
deeper skin layers in comparison to conventional liposomes [10,25]. In this study, we designed the
DLs-in-chitosan hydrogel as a combined advanced delivery system, targeting the treatment of chronic
wounds. Considering that chitosan has lateral amino groups conferring positive charge to its chains,
the incorporation of charged liposomes could trigger interactions between the two delivery systems,
affecting the hydrogel’s texture properties, liposomes’ integrity, and drug release [24]. We therefore
focused on the effect of the liposomal surface charge on the hydrogel’s properties, such as the texture
properties and bioadhesiveness; neutral (NDLs), cationic (CDLs), and anionic (ADLs) DLs were
individually incorporated in chitosan hydrogel.
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The effect of the liposomal surface charge on curcumin penetration from DLs-in-hydrogel systems
through the ex vivo full thickness human skin was also evaluated.
2. Materials and Methods
2.1. Materials
Curcumin (≥94% curcuminoid content; ≥80% curcumin) was purchased from Sigma-Aldrich
(St. Louis, MO, USA). Lipoid S 100 (>94% soybean phosphatidylcholine, PC) was a generous gift
from Lipoid GmbH (Ludwigshafen, Germany). High molecular weight (MW) chitosan (Brookfield
viscosity 800.000 cps and degree of deacetylation of 77%), polysorbate 20, stearylamine (SA), sodium
deoxycholate (SDCh), methanol, disodium hydrogen phosphate dihydrate, monobasic potassium
phosphate, sodium chloride, propylene glycol (PG), glycerol, and acetic acid were all purchased from
Sigma-Aldrich (St. Louis, MO, USA). Albunorm® (human serum albumin, 200 mg/mL) was produced
by Octapharma AG (Lachen, Switzerland).
2.2. Preparation and Characterization of Deformable Liposomes
Curcumin-containing DLs bearing different surface charges were prepared by the film hydration
method as previously described [26]. NDLs comprised PC and polysorbate 20 (total 200 mg), in a
weight ratio of 85:15. CDLs comprised the same lipid and surfactant composition as NDLs, in addition
to SA (weight ratio to PC 1:9). ADLs were composed of PC and SDCh (total 200 mg) in a ratio of 85:15
(w/w) (Table 1). All DLs were prepared by dissolving curcumin (20 mg), PC, and, when applicable,
the different surfactants, in methanol. The organic solvent was evaporated under vacuum (55 mbar)
at 55 ◦C (Büchi Rotavapor R-124 with Büchi Vacuum Pump V-700, Büchi Labortechnik AG, Flawil,
Switzerland) and the obtained film was hydrated with 10 mL of phosphate buffer saline (PBS). PBS
(pH 7.4) contained the following salts composition: 2.98 g/L Na2HPO4·2H2O, 0.19 g/L KH2PO4, 8 g/L
NaCl. The liposomal dispersions were kept at 4 ◦C for 24 h prior to size reduction.










NDLs 2.0 17.0 - - 3.0
CDLs 2.0 15.3 - 1.7 3.0
ADLs 2.0 17.0 3.0 - -
All DLs were reduced to a vesicle size of 200× 300 nm by hand extrusion through the polycarbonate
membrane (Nuclepore® Track-Etched Membranes, Whatman House, Maidstone, UK). In brief, all
DLs were extruded five times through 800-nm pore size membrane. NDLs were further extruded
four times through 400-nm pore size membrane, whereas CDLs and ADLs were extruded through
the same pore size membrane two and seven times, respectively. All liposomal dispersions were
characterized in terms of vesicle size by photon correlation spectroscopy using a NICOMP Submicron
Particle Sizer Model 370 (NICOMP Particle Sizing system, Santa Barbara, CA, USA) and zeta potential
using Malvern Zetasizer Nano—ZS (Malvern, Oxford, UK) [26].
The entrapment efficiency of curcumin in DLs was determined after the centrifugation of the
liposomal dispersion at 3000 g for 10 min using a Biofuge stratos centrifuge (Heraeus instruments
GmbH, Hanau, Germany) to remove unentrapped curcumin. Liposomes were subsequently dissolved
in methanol and the entrapped curcumin determined spectophotometrically at 425 nm (SpectraMax 190
Microplate Reader, Molecular Devices, San Jose, CA, USA). The entrapment efficiency was expressed
as curcumin/lipid ratio (µg/mg), after quantification of the PC content in all DLs formulations (data
not shown).
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2.3. Preparation of Chitosan Hydrogels
Chitosan hydrogels were prepared according to a method described earlier [27]. In short, glycerol
(10%, w/w) was mixed with an aqueous solution of acetic acid (2.5%, w/w). High MW chitosan
(2.5%, w/w) was introduced into the mixture by hand stirring. To remove entrapped air, the mixture
was bath-sonicated for 30 min. The prepared hydrogels were stored in a sealed container at room
temperature for 48 h to allow complete swelling.
2.4. Preparation of DLs-In-Hydrogels
To prepare 10 g of liposomes-in-hydrogel formulation, 1.5 g of the different DLs (15%, w/w) were
individually incorporated in the freshly prepared chitosan hydrogel after it was allowed to swell for
48 h at room temperature (Section 2.3) by hand-stirring [28]. The final concentration of curcumin in the
liposomal hydrogel was 135 µg/g. As a control, free curcumin was incorporated in the hydrogel in the
same concentration after dissolving in PG and subsequent incorporation in chitosan hydrogel by hand
stirring. The DLs-in-hydrogel formulations were kept at room temperature for 2 h prior to further
handling. The homogeneity test was performed to assure that liposomes were well dispersed within
the liposomes-in-hydrogel formulation by sampling (5 aliquots were sampled from various places
within hydrogel) and the curcumin concentration was determined in each aliquot.
2.5. Texture Analysis
All liposomes-in-hydrogel formulations were characterized in terms of the hardness, cohesiveness,
and adhesiveness using a Texture Analyzer TA.XT Plus (Stable Micro Systems Ltd., Surrey, UK) [27].
The hydrogel (25 g) was placed in a beaker and a disc (35 mm in diameter) pushed down into the gel
(distance of 10 mm) and withdrawn at a speed of 4 mm/s. The starting position of the disc was below
the hydrogel surface. The hardness was calculated as the maximal force achieved when the disc was
pushed down into the gel. The cohesiveness was expressed as the work necessary to push down the
disc into the hydrogel while the adhesiveness as the work required during the upwards movement of
the disc. Each formulation was tested five times and the measurements performed in triplicates.
2.6. Bioadhesion Test
The bioadhesion of hydrogels to the skin was tested as described earlier [28]. The full thickness
human skin originated from the abdomen of female patients after plastic surgery. A written consent
was obtained from the patients prior the surgery. No ethical approval was required from the Norwegian
Ethical Committee, since we used skin to be disposed of after the surgery; the experiments were
conducted according to the Declaration of Helsinki principles. The skin was cleared from the
subcutaneous fatty tissue and rinsed with PBS prior the storage at −20 ◦C. The skin was thawed in
PBS ca. 30 min prior to the experiment and subsequently fixed on a rig for Texture Analyzer TA.XT
Plus (Stable micro systems, Surrey, UK). The bioadhesion test was performed by filling a die with
the hydrogel formulation (150 µL), which was consequently pinched onto the skin for 10 s applying
a force of 25 g. The bioadhesion was determined by measuring the force required to detach the die
from the skin (detachment speed of 0.1 mm/s). Moreover, the die was weighed before and after each
bioadhesion test to determine the amount of formulation retained onto the skin surface at the end of
the test. Each formulation was tested five times and the human skin rinsed with ethanol between each
measurement. Tests were conducted in triplicates.
2.7. Hydrogel Stability Testing
To evaluate the chitosan hydrogel stability and the influences of the liposomal surface charge on the
stability of DLs-in-hydrogel, the stability testing was performed after the storage of the DLs-in-chitosan
hydrogels for one month at room temperature (23–24 ◦C). The texture properties (Section 2.5) and
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bioadhesiveness (Section 2.6) of the chitosan hydrogel were determined before (one day after the
formulation was prepared) and after the storage (day 30).
2.8. Ex Vivo Skin Penetration Studies
Ex vivo curcumin penetration from the different DLs-in-chitosan hydrogels was evaluated using
the full thickness human skin in Franz diffusion cells (diffusion area of 1.77 cm2, PermeGear, Bethlehem,
PA, USA) [26]. The human skin originated from the excised skin panni obtained from female patients
who underwent abdominoplasty, after they gave written consent (see Section 2.6). The experiments
were conducted in agreement with the Declaration of Helsinki principles. The human skin for the ex
vivo penetration studies was prepared as described in Section 2.6. The slices of human skin used in the
skin penetration studies had a thickness of 1.10 to 1.30 mm. All DLs-in-chitosan hydrogel formulations
(1.2 mL) were added in the donor chamber, whereas the receptor chamber was filled with 12.0 mL
of Albunorm (5%, v/v) solution in PBS. As a control, curcumin in PG-in-hydrogel served as a control.
The experiments were conducted for 8 h and sampling of the receptor medium (500 µL) was performed
every hour. To maintain the sink conditions, the withdrawn receptor medium was replaced by an equal
volume of fresh Albunorm® (5%, v/v) solution in PBS. The penetrated curcumin was quantified as
described in Section 2.2 using a standard curve of curcumin in Albunorm®/PBS (1:1, v/v). Experiments
were performed in three replicates.
2.9. Statistical Analyses
To determine the level of significance (p < 0.05), statistical analyses were performed using one-way
ANOVA test followed by Bonferroni’s multiple comparisons test performed on GraphPad Prism
version 7.00 for Windows (GraphPad Software, La Jolla, CA, USA).
3. Results and Discussion
Chronic wounds exhibit severe molecular and cellular deficiencies and are heterogenous across
the patient population; therefore, they are difficult to treat. At present, no wound dressing can be
considered as “one size fits all”; however, there is a consensus in the field that chronic wound treatment
should shift from conventional dressings towards precision medicine approaches [14]. It is known that
the remodeling phase of wound healing comprises the deposition of extracellular matrix (ECM) in a
well-defined network prior to wound contraction [3]. Chitosan promotes wound healing via stimulation
of ECM formation as well as facilitating the mobilization, adhesion, and accumulation of red blood cells
and platelets forming blood clots at the wound site [14]. Chitosan hydrogel could therefore be a perfect
vehicle to incorporate bioactive molecules within nanoformulations. The combination of liposomal
curcumin, assuring anti-inflammatory activity, and chitosan, providing wound healing and antimicrobial
activities, could assure a synergistic effect and superior performance. The therapeutic potential of the
novel dressing will be dependent on the characteristics of each component as well as their interplay.
3.1. Liposomal Characteristics
Considering the liposomes-in-hydrogel formulation, the liposomal size is known to influence
both the hydrogel properties and the release of lipophilic compounds from liposomes-in-hydrogel
systems [24]. Therefore, focusing on exploring the effect of the liposomal surface charge on both hydrogel
properties and curcumin penetration through human skin, we aimed to prepare DLs of a similar vesicle
size. The chosen vesicle size range was 200 to 300 nm, which has been suggested as appropriate for
assuring dermal delivery via liposomes by offering the reservoir of the liposome-associated drug in
the skin [29]. The extrusion method, utilized to reduce the vesicle size, allows the manufacturing of
rather homogeneously distributed vesicles in the desired size range, as reported earlier [26]. For each
liposomal dispersion, we adjusted both the number of extrusion cycles and membrane pore size,
obtaining curcumin-containing DLs within the size range of 200 to 300 nm (Table 2), as targeted.
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Moreover, the vesicle size distribution was rather homogeneous for all DLs, as indicated by the rather
low polydispersity.
Table 2. Liposomal characteristics.







NDLs 288.73 ± 2.46 0.17 ± 0.02 –3.03 ± 0.24 51.54 a ± 0.99 43.97 ± 0.85
CDLs 252.24 ± 51.63 0.17 ± 0.01 34.01 ± 0.56 71.94 ± 2.32 55.04 ± 1.78
ADLs 291.54 ± 26.48 0.17 ± 0.01 –34.83 ± 0.64 89.67 ± 14.03 76.40 ± 11.96
Results are presented as mean (n = 3) ± SD. a Significantly lower vs. ADLs (p < 0.05).
DLs bearing different surface charges (Table 2) were obtained by including the selected surfactant
in the liposomal phospholipid bilayers. NDLs comprised polysorbate 20 as a non-ionic surfactant,
which conferred a neutral surface to DLs, as well as the neutral lipid, namely PC. Ionic surfactants
were employed to obtain CDLs and ADLs, respectively. SA was responsible for the positive charge
of CDLs, whereas SDCh conferred the negative charge to ADLs surface, both in agreement with the
literature [30,31].
The entrapment efficiency of curcumin in the different DLs varied according to the liposomal
composition (Table 2). The presence of surfactant might contribute to a lower entrapment of lipophilic
compounds, such as curcumin; both substances are competing for accommodation within the liposomal
phospholipid bilayer. Moreover, it is known that the drug/active substance incorporation capacity
is additionally dependent on the type of employed surfactant [32]. In our case, ADLs exhibited the
highest entrapment efficiency for curcumin. A possible explanation might be the higher lipophilicity
of SDCh compared to polysorbate 20, thus improving the curcumin solubility and therefore enhancing
the curcumin loading capacity for ADLs [32]. The presence of SA in CDLs has been shown to alter the
lipid packing of liposomes by causing a charge repulsion [33]. This can therefore affect curcumin’s
accommodation within the CDLs bilayer, as previously reported for the drugs of a similar lipophilicity
as curcumin, such as celecoxib [34].
3.2. Effect of the Liposomal Surface Charge on the Texture Properties of Liposomes-In-Hydrogel
The development of effective hydrogel-based wound dressings requires their optimization in
terms of hydrogel’s texture properties. For hydrogels as wound dressings, the hydrogel’s hardness can
determine the ease of its application onto the skin, whereas the adhesiveness influences the hydrogel’s
contact time with the skin. These factors consequently contribute to the efficacy of the treatment and
assure patient compliance by reducing the frequencies of administration and the related pain caused
by wound dressing changes [11]. While optimizing liposomes-in-hydrogel formulations, an evaluation
of the texture properties of the hydrogel is required considering that the incorporation of DLs bearing
different surface charges can affect the hydrogel texture properties [24]. Possible interactions between
charged DLs and positive chitosan chains might change/affect the chitosan network, thus modifying its
texture characteristics. The effect of the liposomal surface charge of curcumin-containing DLs on the
hydrogel properties is presented in Table 3.
Table 3. The effect of the liposomal surface charge on the texture properties of liposomes-in-hydrogel.
Chitosan Hydrogel Composition Hardness (g) Cohesiveness (g*s) Adhesiveness (g*s)
Plain hydrogel 164.8 ± 11.1 359.6 ± 10.6 346.8 ± 8.0
CUR-in-hydrogel 148.7 ± 20.1 262.2 ± 17.0 248.5 ± 20.1
CUR-NDL-in-hydrogel 107.0 a ± 4.2 226.5 a,b ± 1.7 216.5 a ± 2.8
CUR-CDL-in-hydrogel 116.8 a ± 6.7 212.3 a,b ± 5.5 200.9 a,b ± 9.4
CUR-ADL-in-hydrogel 124.6 ± 21.0 204.0 a,b ± 13.5 190.7 a,b ± 8.6
Results are presented as mean (n = 3) ± SD. CUR: curcumin. a Significantly lower vs. plain hydrogel (p < 0.05);
b significantly lower vs. CUR-in-hydrogel (p < 0.05).
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The incorporation of DLs negatively affected the original hydrogel texture properties (plain
hydrogel). The incorporation of deformable liposomes weakened the hydrogel properties to a higher
extent than the incorporation of free curcumin (CUR-in-hydrogel, Table 3). Due to the hydrophobic
nature of curcumin, its incorporation in chitosan hydrogel in the form of free curcumin (not incorporated
in DLs) was achieved by prior dispersion of curcumin in PG. The presence of PG has been shown
to exert a positive effect on the viscoelastic properties of hydrogels by triggering hydrogen bonding
between chitosan, water, and the solvent [35]. This might explain the positive effect of free curcumin
in PG on the hydrogel properties compared to DLs. Vanić and co-workers [36] observed changes in
the hydrogel texture properties when deformable propylene glycol liposomes were incorporated in
Carbopol hydrogel; as in our case, the hydrogel texture properties were reduced. The incorporation
of DLs in Carbopol hydrogel also affected the hydrogel texture when compared to a marketed gel
product, although the authors did not focus on the effect of the liposomal surface charge [37]. Similar
to our findings, Hurler and collaborators [24] also observed weakened chitosan hydrogel properties
due to the incorporation of conventional liposomes bearing different surface charges. The charged
DLs enhanced the hydrogel hardness while weakening both the cohesiveness and adhesiveness, as
compared to NDLs (Table 3).
3.3. Effect of Liposomal Surface Charge on Hydrogel Bioadhesion to Human Skin
Bioadhesiveness represents an important feature responsible for the effectiveness of hydrogel-based
wound dressings. Good hydrogel bioadhesion to human skin can prolong the retention time of the
incorporated drug/active substance at the skin site, thus resulting in an enhanced therapeutic effect.
Considering the presence of the exudate in chronic wounds/burns, the contact time of the hydrogel to
the skin might be reduced by a loss of the original hydrogel texture characteristics due to the high
water content in the wounded area of exudating wounds [11]. Improved hydrogel bioadhesion to
human skin might overcome this limitation. We therefore evaluated a possible effect of the liposomal
surface charge on the chitosan hydrogel bioadhesiveness. Based on the method developed earlier in
our laboratory [28], we evaluated the hydrogel bioadhesion to human skin by determining the force
required to remove the hydrogel formulation from the skin (Figure 1a) and the amount of hydrogel
formulations retained onto the skin surface at the end of the bioadhesion test (Figure 1b).
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The bioadhesiveness expressed as the detachment force was not affected by the incorporation
of curcumin-containing DLs, regardless of the liposomal surface charge. Both CDLs- and
ADLs-in-hydrogel exhibited a similar bioadhesiveness as plain hydrogel, whereas NDLs-in-hydrogel
showed the strongest bioadhesion to human skin. As observed for the texture properties, NDLs with a
neutral surface seemed to stabilize the chitosan network to a higher extent compared to the charged
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DLs. Their neutral liposomal surface assures minimal interactions with the polymer, thus leaving
unaltered the intrinsic bioadhesive properties of chitosan hydrogel.
The amount of the hydrogel retained on the skin was similar for all tested DLs-in-hydrogel
systems. Moreover, the high amount of hydrogel retained onto the skin (approximately 70%) observed
for all DLs-in-hydrogel is encouraging considering the need to potentially overcome the challenge
of hydrogel exposure to wound exudate and reduced retention time when hydrogel is applied on
exudate-rich wounded area. The high water content associated to those wound types is responsible for
the limited adhesion of the wound dressing at the skin site. Therefore, the good bioadhesive properties
of DLs-in-hydrogel systems confirmed herewith are promising in prolonging the retention time of
novel dressing, including curcumin, at the wounded area rich in exudate, potentially enhancing its
therapeutic outcome. Further studies involving the exposure to wound exudate are required to confirm
these preliminary findings.
3.4. Stability of Hydrogel
The incorporation of charged DLs in chitosan hydrogel has shown to influence, to a higher extent,
the hydrogel’s texture properties (Table 2) and, to a lesser extent, the bioadhesiveness (Figure 1),
possibly attributable to triggered interactions between charged DLs and chitosan. We therefore further
explored the effect of the liposomal surface charge on the stability of liposomes-in-hydrogel. Wound
dressings that can maintain their original properties when stored at room temperature would enable
easier administration both by the patient itself or a caretaker. The liposomes-in-hydrogel formulations
were stored at room temperature (23–24 ◦C) for one month and both the texture properties and
bioadhesiveness of formulations were determined and compared with the properties of the original
formulations. As expected, the original texture properties were preserved to a higher extent when
NDLs were incorporated in the hydrogel compared to both CDLs and ADLs (Figure 2). The minimal
interaction between neutral DLs and chitosan network seems to maintain the original hydrogel texture
properties whereas the charged DLs weakened the texture properties due to electrostatic interactions.
However, the findings were still considered acceptable, considering that the testing was performed at
room temperature.
Interestingly, the evaluation of the hydrogel’s stability in terms of its bioadhesiveness showed
that the original bioadhesion to human skin was better preserved when CDLs were incorporated in the
hydrogel (Figure 3). Both the detachment force (Figure 3a) and the amount of formulation retained
onto the skin surface (Figure 3b) for CDLs-in-hydrogel moderately increased compared to both NDLs-
and ADLs-in-chitosan hydrogel. However, the differences were not significant, and more experiments
would be required to confirm the observed trend.
Although the original bioadhesiveness of liposomes-in-hydrogel was enhanced by the presence
of NDLs, suggesting that the neutral surface of NDLs might exert a positive effect on hydrogel
bioadhesiveness (Figure 1), the results from the hydrogel stability testing indicate that the positively
charged DLs can better preserve hydrogel bioadhesiveness for a longer time as compared to NDLs.
Considering the variability of human skin in respect to the source, the differences were not significant.
The repulsion between positive CDLs and chitosan chains might stabilize the liposomes in the hydrogel
matrix, thus preserving chitosan bioadhesion to human skin.
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The bioadhesiveness of the dressing is one of the main factors determining the time curcumin is
retained at the skin site. Despite the rather negative effect of charged liposomes on the texture properties
of DLs-in-hydrogel, the incorporation of CDLs in hydrogel might increase hydrogel bioadhesiveness,
thus assuring a longer time for curcumin to exert its biological activities. The significance of the
superiority of CDLs in hydrogels needs to be confirmed. For co parison, visual evaluation of the
hydrogels stored for one month indicated that the control, namely curcumin-in-hydrogel (non-liposomal
curcumin in hydrogel), exhibited clear curcumin precipitation (data not shown). This was additional
conformation that to deliver curcumin at the wounded site, combined formulations comprising
liposomes and hydrogel are highly advantageous.
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3.5. Ex Vivo Curcumin Penetration from DLs-In-Hydrogel into Human Skin
As dermal delivery systems, both DLs and chitosan hydrogel have shown ability to assure
controlled and sustained skin penetration of the associated drug. When used in combination, this
action can be enhanced and, together with the prolonged retention time at the targeted skin site,
might lead to improved localized wound therapy [18,19]. Moreover, this can result in a reduction in
frequency of wound dressings’ changes, improving patient compliance and the easiness of dressing
administration. The inc rporation of curcumin-DLs in the hydrogel introduces additional barriers that
curcumin has to face n cross before reaching the targeted site. Therefore, curcumin r lease from the
DLs-in-hydrogel f llowed by its skin penetrati n is a complex process and depends on several factors.
The lipophilicity of curcumin will influence this process, especially its partitioning into the hydrogel,
whereas its aqueous solubility will determine the diffusion rate through the hydrophilic hydrogel
matrix, as reported for other lipophilic compou s [38]. The lip som l surface charge repre ents an
additional factor that c affect curcumin penetration through/into the skin [39]. Moreover, due to the
positively charged chitosan chains, t e liposomal surface charge can determine possible interaction
between DLs and chitosan [24]. This can affect the integrity of the liposomal bilayer when embedded
into the hydrogel, thus influencing the release of curcumin. By exploring the abovementioned factors,
the development of liposomes-in-hydrogel formulations for controlled dermal delivery of curcumin
can be tailored and effective therapy assured.
Figure 4 presents the skin penetration profiles of curcumin from the different curcumin-DLs-in-
hydrogel systems. A minimal amount of penetrated curcumin was detected, regardless of the liposomal
surface charge. This can be contributed to the slow diffusion of curcumin when released into the
hydrophilic hydrogel due to its poor water solubility. In agreement with our findings, Jain and
collaborators [25] also reported a rather slow in vitro release of curcumin from lipospheres embedded
in hydroxyl propyl methyl cellulose-based gel.
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As a control, curcumin-in-hydrogel was used; curcumin was incorporated in the hydrogel in a
form of solution in PG in the same concentration as in DLs.
The NDLs-in-hydrogel release profile exhibited the highest amount of penetrated curcumin, even
in comparison to curcumin-in-hydrogel (Figure 4). However, the differences were not statistically
different and can only be considered as a trend. It is important to point out that the experiments
were performed using human skin of different donors, adding to larger SD. NDLs with their neutral
surface are not expected to interact with the chitosan chains. The minimal interaction between NDLs
and chitosan chains might also marginally interfere with NDLs’ mobility within the polymer matrix,
allowing faster curcumin delivery into/through the skin via NDLs. Thomas and collaborators [40]
reported the enhancement of curcumin skin penetration from nanosystems-in-chitosan hydrogel
compared to free curcumin-in-hydrogel. They incorporated curcumin in nanoemulsions further
incorporated in chitosan hydrogel and observed a higher rat skin penetration of curcumin as compared
to free curcumin-in-hydrogel. Sun and co-workers [41] reported higher penetration of curcumin from
PLGA nanoparticles-loaded in Carbopol gel compared to free curcumin-in-gel, although they tested
the formulations on mouse skin.
The charged DLs-in-hydrogel exhibited more sustained, although not significant, skin penetration
of curcumin compared to NDLs-in-hydrogel and control (curcumin-in-hydrogel). Considering the
possible electrostatic interactions that can be triggered when charged DLs are embedded into the chitosan
network, the liposomal membrane might be more preserved, thus li iting curcumin partitioning into
the hydrogel. The electrostatic interactions between negative DLs and positive chitosan chains can
cause immobilization of ADLs within the hydrogel matrix, thus limiting initial curcumin diffusion into
the hydrogel prior to reaching the skin. El Kechai and collaborators [42] proposed low mobility of
liposomes bearing opposite charge to the hydrogel chains; the authors observed that positive liposomes
were highly immobilized in the negative hyaluronic acid hydrogel. On the other hand, the higher
repulsion occurring between CDLs and chitosan, both positively charged, might stabilize the CDLs
membrane and limit curcumin partitioning into the chitosan hydrogel. Hurler and collaborators [24]
also observed a similar release pattern when testing the in vitro release of a lipophilic compound from
positively charged liposomes embedded in chitosan hydrogel, in agreement with our findings.
In our previous work [10], we showed a successful inhibition of S. aureus and S. pyogenes growth
when testing curcumin in deformable liposomes in a curcumin concentration of 100 and 200 µg/mL.
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Furthermore, the curcumin-containing liposomes (even at a curcumin concentration of 2.5 µg/mL)
successfully inhibited nitric oxide production. The concentrations used in the current study are in the
same range as the ones in the aforementioned study, indicating that the delivery rate is compatible
with the working concentration of curcumin in this type of carrier. Compared to Ternullo et al. [10],
the ex vivo release through full thickness human skin exhibited a more sustained release when
the DLs were incorporated into a hydrogel, as expected. Recently, Nguyen and coauthors [43]
reported improved wound healing when utilizing a curcumin–oligochitosan nanoparticle complex
and oligochitosan-coated curcumin-loaded liposomes with a curcumin concentration of 100 µg/mL.
The hydrogel prepared in the current study contains curcumin in a concentration of 135 µg/g and is
therefore similar to the concentration used by Nguen et al. (2019). The curcumin concentration in the
novel dressing is sufficient to achieve the desired biological response.
Considering the prolonged retention time of curcumin assured by chitosan hydrogel and sustained
delivery provided by liposomes-in-hydrogel, we can postulate that curcumin will have a sufficient
time and required concentration at the skin site to exert its therapeutic effect. However, the findings
should be further explored in a suitable wound model.
4. Conclusions
To utilize the wound healing potential of both curcumin and chitosan, we developed a novel
wound dressing comprising curcumin-in-liposomes-in-chitosan hydrogel. Curcumin was incorporated
in deformable liposomes of various surface charges and the effect of the liposomal surface charge on
the performance of chitosan hydrogels was evaluated. Although the original texture properties were
changed to a certain degree upon inclusion of the charged liposomes, the incorporation of DLS in
the chitosan hydrogel did not affect its bioadhesiveness. Neutral deformable liposomes-in-hydrogel
exhibited the strongest bioadhesiveness; however, their neutral surface did not preserve the hydrogels´s
bioadhesion to human skin over longer storage times. The positively charged deformable liposomes
exhibited an ability to stabilize the formulation’s bioadhesiveness and additionally assured sustained
penetration of curcumin through the ex vivo full human skin. The developed advanced dermal delivery
system is therefore promising as a wound dressing.
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